M Santoni
Overview
Explore the profile of M Santoni including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
418
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Minardi D, Scartozzi M, Montesi L, Santoni M, Burattini L, Bianconi M, et al.
Springerplus
. 2015 Jun;
4:255.
PMID: 26085975
Purpose: Evidences have shown that neutrophil-to-lymphocyte ratio (NLR) has a prognostic value in patients with cancer. We wanted to test the prognostic significance of NLR in prostatic cancer of patients...
12.
Santoni M, Scarpelli M, Mazzucchelli R, Lopez-Beltran A, Cheng L, Cascinu S, et al.
J Biol Regul Homeost Agents
. 2015 Jan;
28(4):555-63.
PMID: 25620167
Prostate-specific membrane antigen (PSMA) is an integral, non-shed membrane glycoprotein that is highly expressed on prostate epithelial cells and strongly upregulated in prostate cancer (PCa). Prostatic neoplastic transformation results in...
13.
Massari F, Santoni M, Ciccarese C, Santini D, Alfieri S, Martignoni G, et al.
Cancer Treat Rev
. 2015 Jan;
41(2):114-21.
PMID: 25586601
RCC is considered an immunogenic tumor with a prominent dysfunctional immune cell infiltrate, unable to control tumor growth. Evasion of immune surveillance, a process defined immune-editing, leads to malignant progression....
14.
Santoni M, De Giorgi U, Iacovelli R, Conti A, Burattini L, Rossi L, et al.
Br J Cancer
. 2013 Sep;
109(7):1755-9.
PMID: 24008663
Background: Everolimus is a mammalian target of rapamycin inhibitor approved for the treatment of metastatic renal cell carcinoma (mRCC). We aimed to assess the association between pre-treatment neutrophil-to-lymphocyte ratio (NLR)...
15.
Iacovelli R, Altavilla A, Procopio G, Bracarda S, Santoni M, Cascinu S, et al.
Prostate Cancer Prostatic Dis
. 2013 Jul;
16(4):323-7.
PMID: 23896627
Background: About 20% of patients with prostate cancer have an ECOG performance status (PS) 2 at diagnosis. We investigate if current treatment options for castration-resistant prostate cancer (CRPC) may decrease...
16.
Santoni M, Amantini C, Morelli M, Liberati S, Farfariello V, Nabissi M, et al.
Br J Cancer
. 2013 Jul;
109(4):1040-50.
PMID: 23887605
Background: Tyrosine kinase inhibitors (TKI) such as sunitinib and pazopanib display their efficacy in a variety of solid tumours. However, their use in therapy is limited by the lack of...
17.
Santoni M, Paccapelo A, Burattini L, Onofri A, Cascinu S
Anticancer Res
. 2012 Mar;
32(3):1099-101.
PMID: 22399639
Alkylating agents, such as temozolomide (TMZ) and fotemustine (FTM) are widely used in recurrent glioblastoma (GBM) regimes. Several strategies have been proposed to prevent resistance to these agents, by combining...
18.
Cellerini M, Konze A, Caracchini G, Santoni M, Dal Pozzo G
Acta Anat (Basel)
. 1997 Jan;
158(3):215-21.
PMID: 9394958
Rapid scan techniques have introduced new sequence parameters as well as novel contrast concepts into everyday magnetic resonance imaging (MRI). In particular contrast characteristics of fast-spin echo (FSE) sequences showed...
19.
Felici L, Santoni M, Carloni I, Coppa G
Eur J Pediatr
. 1996 Nov;
155(11):994.
PMID: 8911908
No abstract available.
20.
Rahimi S, Santoni M, Muda A
Gen Diagn Pathol
. 1996 Oct;
142(2):109-11.
PMID: 8950577
The histologic and immunohistochemical features of a case of adult solitary cutaneous myofibroma are reported. The lesion consisted of interlacing bundles of spindle cells arranged around small vessels with hemangiopericytomatous...